Metraipolis › archive › dc_4bac2c620de5

Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East… — Europe PMC PMID:42141483

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42141483
DOI
10.1186/s13063-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-01T16:18:23.721Z
SHA-256 of the archived text
7d8a2fc7ba371ab12492cb92b4d742df41c264feb0b1c89c67653534c3e9927b
Stable URL of this page
https://metraipolis.com/documento/dc_4bac2c620de5

How to cite

Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East… — Europe PMC PMID:42141483 — Europe PMC (en), https://europepmc.org/article/MED/42141483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bac2c620de5 (Metraipolis archive dc_4bac2c620de5, sha256 7d8a2fc7ba371ab12492cb92b4d742df41c264feb0b1c89c67653534c3e9927b)
BibTeX
@misc{dc4bac2c620de5,
  title = {Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East… — Europe PMC PMID:42141483},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42141483},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bac2c620de5; sha256 7d8a2fc7ba371ab12492cb92b4d742df41c264feb0b1c89c67653534c3e9927b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42141483. Agents can read the archived copy with the MCP tool read_document.